Mersen shares down 1.5%, -10.5% over one month after a well-received Q3

Another decline that widens the gap with short-term moving averages

Mersen shares fell 1.35% to €36.60 intraday, while the CAC 40 was stable and the SBF 120 unchanged. The stock is among the largest decliners on the SBF 120 and outperforms some more heavily hit stocks, such as Eramet, which is down nearly 7%.

The stock now trades 3.33% below its MM20 and 6.47% below its MM50, extending the slide begun a week ago, when it had still gained more than 2% on November 10. It remains, however, 4.30% above its MM200, at €35.09, just a few cents above the €35.04 support level.

Over one month, the loss reaches 10.25%, a decline that contrasts with the gain of more than 71% recorded over twelve months.

A 2026 target raised at the end of October, which did not prevent the decline of recent sessions

On October 28, when the third-quarter results were published, Mersen raised for the second time this year its 2026 organic growth target, now between 6.5% and 7.5%, versus 4% to 6% previously.

The group also confirmed its margin objectives, with quarterly revenue of €329.2 million, up 14.2% organically.

This publication had been welcomed by an 8% rise the following day, but the stock has since given back part of its gains, to the point of falling below its MM20 on Thursday. The RSI at 45 remains neutral, and the holding of the €35.04 support level will be the level to watch in the coming sessions.